28 results
Thumbnail

D3.399 - An SYK Variant with Variable Spectrum of Immunodeficiency and Immune Dysregulation: Case Series

Thumbnail

D3.409 - Immunological Mechanisms in Treatment-Resistant Depression

Thumbnail

D3.413 - Basophil Activation Test Positivity and Response to Ciclosporin in Chronic Spontaneous Urticaria: A Real-World Exploratory Study

Thumbnail

D3.414 - Clinical and Laboratory Predictors of Basophil Activation Test Positivity in Chronic Spontaneous Urticaria: A Real-World Exploratory Study

Thumbnail

D3.416 - PEG-CUR Reduces Oxidative Stress and Total Methylation Induced by Cigarette Smoke in Epithelial Cells: Development of PEG-Curcumin Loaded Fast-Dissolving Microneedle Patches

Thumbnail

D3.398 - Primary Care Physicians’ Perspectives on Primary Immunodeficiency Diseases

Thumbnail

D3.401 - A mechanism for loss of biodiversity in the gut: Toxic effects and metabolic alterations of food additives on human fecal microbiome

Thumbnail

D3.402 - Evaluation of Apigenin's Anti-Inflammatory and Wound Healing Effects Using Atopic Dermatitis Cell Culture Model

Thumbnail

D3.403 - Protein Profiling of CAR-Engineered NK92-Derived Exosomes Using Western Blot

Thumbnail

D3.404 - From CVID to CTLA-4 Haploinsufficiency: The Impact of Genetic Diagnosis on Targeted Therapy

Thumbnail

D3.406 - Novel bone materials selectively modulate the human immune response to favor remodeling over acute inflammation

Thumbnail

D3.407 - Angioedema: cause or consequence?

Thumbnail

D3.408 - When Angioedema Is Not Angioedema: EBV-Associated Lymphocytic Inflammation Mimicking Hereditary Angioedema

Thumbnail

D3.415 - Galectin-10 Expression in Plasma-Derived Extracellular Vesicles of Patients with Eosinophilic Esophagitis: a Pilot Study

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials

Thumbnail

D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use